NIVAQUINE 100 mg, scored tablet 20 tablets
Active ingredients: Chloroquine, Chloroquine sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIVAQUINE 100 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) PVC-Aluminium de 10 comprimé(s)
- Marketing authorisation holder
- SANOFI AVENTIS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Oct 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65130778CIP73073117CIP133400930731178Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE CHLOROQUINEcomprimé | 136 mg · un comprimé | SA |
| CHLOROQUINEcomprimé | 100 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.